Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial Tc-99m-DMSA SPECT/CT
RIS ID
97240
Abstract
Background: Stereotactic ablative body radiotherapy (SABR) has been proposed as a definitive treatment for patients with inoperable primary renal cell carcinoma. However, there is little documentation detailing the radiobiological effects of hypofractionated radiation on healthy renal tissue.
Publication Details
Jackson, P., Foroudi, F., Pham, D., Hofman, M. S., Hardcastle, N. G., Callahan, J., Kron, T. & Siva, S. (2014). Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial Tc-99m-DMSA SPECT/CT. Radiation Oncology, 9 (253), 1-4.